Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Naples, Italy.
Medical Genetics, Department of Medical and Translational Sciences, Federico II University, Naples, Italy.
Nat Rev Mol Cell Biol. 2020 Feb;21(2):101-118. doi: 10.1038/s41580-019-0185-4. Epub 2019 Nov 25.
Exciting new discoveries have transformed the view of the lysosome from a static organelle dedicated to the disposal and recycling of cellular waste to a highly dynamic structure that mediates the adaptation of cell metabolism to environmental cues. Lysosome-mediated signalling pathways and transcription programmes are able to sense the status of cellular metabolism and control the switch between anabolism and catabolism by regulating lysosomal biogenesis and autophagy. The lysosome also extensively communicates with other cellular structures by exchanging content and information and by establishing membrane contact sites. It is now clear that lysosome positioning is a dynamically regulated process and a crucial determinant of lysosomal function. Finally, growing evidence indicates that the role of lysosomal dysfunction in human diseases goes beyond rare inherited diseases, such as lysosomal storage disorders, to include common neurodegenerative and metabolic diseases, as well as cancer. Together, these discoveries highlight the lysosome as a regulatory hub for cellular and organismal homeostasis, and an attractive therapeutic target for a broad variety of disease conditions.
令人兴奋的新发现改变了人们对溶酶体的看法,从一个专门处理和回收细胞废物的静态细胞器转变为一个高度动态的结构,介导细胞代谢对环境信号的适应。溶酶体介导的信号通路和转录程序能够感知细胞代谢的状态,并通过调节溶酶体发生和自噬来控制合成代谢和分解代谢之间的转换。溶酶体还通过交换内容和信息以及建立膜接触位点与其他细胞结构广泛通讯。现在很清楚,溶酶体的定位是一个动态调节的过程,是溶酶体功能的关键决定因素。最后,越来越多的证据表明,溶酶体功能障碍在人类疾病中的作用不仅限于罕见的遗传性疾病,如溶酶体贮积症,还包括常见的神经退行性和代谢性疾病以及癌症。这些发现共同强调了溶酶体作为细胞和机体稳态的调节中心,以及治疗多种疾病的有吸引力的治疗靶点。